Activated coagulation time vs. intrinsically activated modified rotational thromboelastometry in assessment of hemostatic disturbances and blood loss after protamine administration in elective cardiac surgery: analysis from the clinical trial (NCT01281397)

Mate Petricevic, Bojan Biocina, Davor Milicic, Lucija Svetina, Marko Boban, Ante Lekić, Sanja Konosic, Milan Milosevic, Hrvoje Gasparovic, Mate Petricevic, Bojan Biocina, Davor Milicic, Lucija Svetina, Marko Boban, Ante Lekić, Sanja Konosic, Milan Milosevic, Hrvoje Gasparovic

Abstract

Background: Excessive bleeding after cardiopulmonary bypass (CPB) is risk factor for adverse outcomes after elective cardiac surgery (ECS). Although many different point-of-care devices to diagnose hemostatic disturbances after CPB are available, the best test is still unclear. The study aim was to compare the accuracy of hemostatic disorder detection between two point-of-care devices.

Methods: We enrolled 148 patients (105 male and 43 female) undergoing ECS in a prospective observational study. Rotational thromboelastometry (TEM, with InTEM test), and Activated coagulation time (ACT) measurement were performed 15 min after protamine administration. The cohort group was divided into two subgroups according to occurrence of excessive postoperative bleeding. Endpoints were defined in two ways: as total amount of chest tube output (CTO) and blood product transfusion requirements.

Results: Total amount of CTO value of 1507,50 mL presented 75th percentile of distribution, thus cut-off value for bleeder category. InTEM parameters, but not ACT, correlated significantly with CTO. InTEM parameters with the strongest correlation to CTO were tested for accuracy in predicting excessive postoperative bleeding using ROC analysis. InTEM A 10 value of 38 mm, InTEM A 20 value of 49 mm and InTEM A 30 value of 51 mm delineated bleeding tendency. Patients with total amount of CTO exceeding 75th percentile were more frequently transfused with fresh frozen plasma (51.4% vs. 9.9%, p < 0.001), fibrinogen concentrate (21.6% vs. 2.7%, p = 0.001) and platelet concentrate (13.5% vs. 0.9%, p = 0.004).

Conclusion: Our study showed that InTEM test, but not ACT is useful in prediction of bleeding tendency after protamine administration following weaning from CPB. InTEM test could be used as a first line test in screening of possible hemostatic disorder following protamine administration.

Trial registration: ClinicalTrials.gov NCT01281397.

Figures

Figure 1
Figure 1
Receiver operating curve analysis for excessive bleeding prediction using (a) InTEM A 10 test (AUC 0.636, p = 0.02) , (b) InTEM A 20 test (AUC 0.632, p = 0.02) and by (c) InTEM A 30 test (AUC 0.630, p = 0.02).

References

    1. Woodman RC, Harker LA. Bleeding complications associated with cardiopulmonary bypass. Blood. 1990;76:1680–1697.
    1. Dixon B, Santamaria JD, Reid D, Collins M, Rechnitzer T, Newcomb AE, Nixon I, Yii M, Rosalion A, Campbell DJ. The association of blood transfusion with mortality after cardiac surgery: cause or confounding? (CME) Transfusion. 2013;53:19–27. doi: 10.1111/j.1537-2995.2012.03697.x.
    1. Spiess BD, Tuman KJ, McCarthy RJ, DeLaria GA, Schillo R, Ivankovich AD. Thromboelastography as an indicator of post-cardiopulmonary bypass coagulopathies. J Clin Monit. 1987;3:25–30. doi: 10.1007/BF00770880.
    1. Ti LK, Cheong KF, Chen FG. Prediction of excessive bleeding after coronary artery bypass graft surgery: the influence of timing and heparinase on thromboelastography. J Cardiothorac Vasc Anesth. 2002;16:545–550. doi: 10.1053/jcan.2002.126945.
    1. Hattersley PG. Activated coagulation time of whole blood. JAMA. 1966;196:436–440. doi: 10.1001/jama.1966.03100180108036.
    1. Murray DJ, Brosnahan WJ, Pennell B, Kapalanski D, Weiler JM, Olson J. Heparin detection by the activated coagulation time: a comparison of the sensitivity of coagulation tests and heparin assays. J Cardiothorac Vasc Anesth. 1997;11:24–28. doi: 10.1016/S1053-0770(97)90247-0.
    1. Petricevic MBB, Burcar I, Konosic S, Ivancan V, Gabelica R, Siric F, Kopjar T, Berkovic V, Gasparovic H. Activated coagulation time vs. intrinsically activated modified rotational thromboelastometry in assessment of hemostatic disturbances and blood loss after protamine administration in elective cardiac surgery: analysis from the clinical trial (NCT01281397). In Book Activated coagulation time vs. intrinsically activated modified rotational thromboelastometry in assessment of hemostatic disturbances and blood loss after protamine administration in elective cardiac surgery: analysis from the clinical trial (NCT01281397) J Cardiothoracic Surg. 2013;8:109. doi: 10.1186/1749-8090-8-S1-P122.
    1. Entholzner EK, Mielke LL, Calatzis AN, Feyh J, Hipp R, Hargasser SR. Coagulation effects of a recently developed hydroxyethyl starch (HES 130/0.4) compared to hydroxyethyl starches with higher molecular weight. Acta Anaesthesiol Scand. 2000;44:1116–1121. doi: 10.1034/j.1399-6576.2000.440914.x.
    1. Kurec AS, Morris MW, Davey FR. Clotting, activated partial thromboplastin and coagulation times in monitoring heparin therapy. Ann Clin Lab Sci. 1979;9:494–500.
    1. Metz CE. Basic principles of ROC analysis. Semin Nucl Med. 1978;8:283–298. doi: 10.1016/S0001-2998(78)80014-2.
    1. Paparella D, Brister SJ, Buchanan MR. Coagulation disorders of cardiopulmonary bypass: a review. Intensive Care Med. 2004;30:1873–1881. doi: 10.1007/s00134-004-2388-0.
    1. Galeone A, Rotunno C, Guida P, Bisceglie A, Rubino G, Schinosa Lde L, Paparella D. Monitoring incomplete heparin reversal and heparin rebound after cardiac surgery. J Cardiothorac Vasc Anesth. 2013;27:853–858. doi: 10.1053/j.jvca.2012.10.020.
    1. Metz S, Keats AS. Low activated coagulation time during cardiopulmonary bypass does not increase postoperative bleeding. Ann Thorac Surg. 1990;49:440–444. doi: 10.1016/0003-4975(90)90251-Z.
    1. Mittermayr M, Margreiter J, Velik-Salchner C, Klingler A, Streif W, Fries D, Innerhofer P. Effects of protamine and heparin can be detected and easily differentiated by modified thrombelastography (Rotem): an in vitro study. Br J Anaesth. 2005;95:310–316. doi: 10.1093/bja/aei197.
    1. Spiess BD, Gillies BS, Chandler W, Verrier E. Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients. J Cardiothorac Vasc Anesth. 1995;9:168–173. doi: 10.1016/S1053-0770(05)80189-2.
    1. Green JA, Spiess BD. Current status of antifibrinolytics in cardiopulmonary bypass and elective deep hypothermic circulatory arrest. Anesthesiol Clin North America. 2003;21:527–551. doi: 10.1016/S0889-8537(03)00042-7.
    1. Boyle EM, Jr, Verrier ED, Spiess BD. Endothelial cell injury in cardiovascular surgery: the procoagulant response. Ann Thorac Surg. 1996;62:1549–1557. doi: 10.1016/0003-4975(96)00836-3.
    1. Slaughter TF, Faghih F, Greenberg CS, Leslie JB, Sladen RN. The effects of epsilon-aminocaproic acid on fibrinolysis and thrombin generation during cardiac surgery. Anesth Analg. 1997;85:1221–1226.
    1. Ray MJ, Marsh NA, Hawson GA. Relationship of fibrinolysis and platelet function to bleeding after cardiopulmonary bypass. Blood Coagul Fibrinolysis. 1994;5:679–685. doi: 10.1097/00001721-199410000-00002.
    1. Despotis GJ, Santoro SA, Spitznagel E, Kater KM, Cox JL, Barnes P, Lappas DG. Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg. 1994;107:271–279.
    1. Spiess BD. The contribution of fibrinolysis to postbypass bleeding. J Cardiothorac Vasc Anesth. 1991;5:13–17. doi: 10.1016/1053-0770(91)90081-4.
    1. Tuman KJ, Spiess BD, McCarthy RJ, Ivankovich AD. Comparison of viscoelastic measures of coagulation after cardiopulmonary bypass. Anesth Analg. 1989;69:69–75. doi: 10.1213/00000539-198907000-00013.
    1. Pina-Cabral JM, Ribeiro-da-Silva A, Almeida-Dias A. Platelet sequestration during hypothermia in dogs treated with sulphinpyrazone and ticlopidine–reversibility accelerated after intra-abdominal rewarming. Thromb Haemost. 1985;54:838–841.
    1. Yoshihara H, Yamamoto T, Mihara H. Changes in coagulation and fibrinolysis occurring in dogs during hypothermia. Thromb Res. 1985;37:503–512. doi: 10.1016/0049-3848(85)90096-9.
    1. Michelson AD, MacGregor H, Barnard MR, Kestin AS, Rohrer MJ, Valeri CR. Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro. Thromb Haemost. 1994;71:633–640.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera